首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a clinical study.
【24h】

Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a clinical study.

机译:通过电喷雾电离LC-MS / MS同时测定人血浆中的瑞舒伐他汀和非诺贝特酸:测定方法的开发,验证和在临床研究中的应用。

获取原文
获取原文并翻译 | 示例
           

摘要

A simple, sensitive and specific LC-MS/MS method for simultaneous determination of rosuvastatin (RST) and fenofibric acid (FFA) was developed and validated with 500 microL human plasma using carbamazepine as an internal standard (IS). The assay procedure involved a simple one-step liquid/liquid extraction of RST and FFA and IS from plasma into ethyl acetate. The organic layer was separated and evaporated under a gentle stream of nitrogen at 40 degrees C. The residue was reconstituted in the mobile phase and injected onto X-Terra MS C-18 column (4.6 mm x 50 mm, 5.0 microm). Separation of RST, FFA and IS was achieved with a mobile phase consisting of 0.05 M formic acid:acetonitrile (45:55, v/v) at a flow rate of 0.40 ml/min. The API-3000LC-MS/MS was operated under the multiple reaction-monitoring mode (MRM) using the electrospray ionization technique. Positive ion acquisition chromatographic run was used in the present method. Nominal retention times of RST, FFA and IS were 2.35, 4.70 and 2.32 min, respectively. Absolute recovery of RST, FFA and IS was 74, 61 and 69%, respectively. The lower limit of quantification (LLOQ) of RST and FFA was 1.00 ng/ml and 0.50 microg/ml, respectively. Response function was established for the range of concentrations 1.00-50.0 ng/ml and 0.50-20.0 microg/ml for RST and FFA, respectively, with a coefficient of determination (r2) of 0.999 for both the compounds. The inter- and intra-day precision in the measurement of RST quality control (QC) samples 5, 15, 400 and 800 ng/ml, were in the range 8.93-9.37% relative standard deviation (R.S.D.) and 1.74-16.1% R.S.D., respectively. Similarly, the inter- and intra-day precision in the measurement of FFA quality control (QC) samples 0.5, 1.5, 8.0 and 15.0 microg/ml, were in the range 9.78-11.6% relative standard deviation (R.S.D.) and 0.22-17.4% R.S.D., respectively. Accuracy in the measurement of QC samples for RST and FFA were in the range 88.1-108 and 87-115%, respectively, of the nominal values. RST and FFA were stable in the battery of stability studies, viz., bench-top, auto-sampler and freeze/thaw cycles. Stability of RST and FFA was established for 1 month at -80 degrees C. The application of the assay to a clinical study confirmed the utility of the assay.
机译:建立了同时测定瑞舒伐他汀(RST)和非诺贝特酸(FFA)的简单,灵敏,特异的LC-MS / MS方法,并以卡马西平为内标(IS)用500微升人血浆进行了验证。测定过程涉及从血浆到乙酸乙酯的简单一步法液/液萃取RST和FFA和IS。分离有机层,并在温和的氮气流中在40摄氏度下蒸发。将残留物重构为流动相,然后注入X-Terra MS C-18色谱柱(4.6 mm x 50 mm,5.0微米)。 RST,FFA和IS的分离是通过流动相(流速为0.40 ml / min)组成的,流动相为0.05 M甲酸:乙腈(45:55,v / v)。 API-3000LC-MS / MS使用电喷雾电离技术在多重反应监控模式(MRM)下运行。本方法使用正离子采集色谱运行。 RST,FFA和IS的名义保留时间分别为2.35、4.70和2.32分钟。 RST,FFA和IS的绝对回收率分别为74%,61%和69%。 RST和FFA的定量下限(LLOQ)分别为1.00 ng / ml和0.50 microg / ml。对于RST和FFA,分别在1.00-50.0 ng / ml和0.50-20.0 microg / ml的浓度范围内建立了响应函数,两种化合物的测定系数(r2)为0.999。 RST质量控制(QC)样品5、15、400和800 ng / ml的日间和日内精度在8.93-9.37%相对标准偏差(RSD)和1.74-16.1%RSD范围内, 分别。同样,FFA质量控制(QC)样品0.5、1.5、8.0和15.0 microg / ml的日间和日内精度在9.78-11.6%相对标准偏差(RSD)和0.22-17.4之间相对标准偏差百分比。 RST和FFA的质量控制样品的测量准确度分别在标称值的88.1-108和87-115%范围内。 RST和FFA在一系列稳定性研究中是稳定的,即台式,自动进样器和冷冻/解冻循环。在-80℃下建立RST和FFA的稳定性达1个月。将该测定法应用于临床研究证实了该测定法的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号